Evidence map›Paper›PMID 35528830›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Huangkui Capsule Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Macrophage Activation by Suppressing Inflammation and Oxidative Stress in Mice.

Jinfang Deng, Zhenpeng He, Xiuru Li, Wei Chen, Ziwen Yu, Ting Qi, Shuangyi Xu, Zhengxin Xu, Lei Fang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. The Lectin fromInternational journal of molecular sciences · 2026
    Article
  3. Therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  4. Review
  5. Neuroprotective Effect ofBioengineering (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jinfang DengDepartment of Pathlogy, First Medical Center of PLA General Hospital, Beijing 100853, China.ORCID https://orcid.org/0000-0001-7910-167X
Zhenpeng HeInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Xiuru LiInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Wei ChenDepartment of Pathlogy, First Medical Center of PLA General Hospital, Beijing 100853, China.
Ziwen YuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Ting QiInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Shuangyi XuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
Zhengxin XuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.ORCID https://orcid.org/0000-0002-0649-3622
Lei FangInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.ORCID https://orcid.org/0000-0001-9980-8285
Yangzhou University · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Huangkui capsule (HKC) comprises the total flavonoid extract of flowers of Methods: Enzyme-linked immunosorbent assay, histopathology, spectrophotometry, and quantitative real-time polymerase chain reaction were used for the assessments. Statistical analysis was performed using a one-way analysis of variance. Results: LPS significantly increased lung inflammation, neutrophil infiltration, and oxidative stress and downregulated lung miR-451 expression. Treatment with HKC dramatically, reduced the total cell count in the bronchoalveolar lavage fluid (BALF), and inhibited myeloperoxidase activity in the lung tissues 24 h after LPS challenge. Histopathological analysis demonstrated that HKC attenuated LPS-induced tissue oedema and neutrophil infiltration in the lung tissues. Additionally, the concentrations of tumour necrosis factor- (TNF-) Conclusions: These findings suggest that HKC has anti-inflammatory and antioxidative effects that may protect mice against LPS-induced ALI and macrophage activation.

Identifiers

PMID35528830
PMCPMC9068299
OpenAlexW3201162405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.